Therapeutic Apheresis and Dialysis

How to Apply and Adapt International Guidelines on Bone Metabolism and Disease to the Management of Japanese Dialysis Patients
pp. 1-2(2)

Abstracts from the 3rd Slovenian Congress of Nephrology
pp. 3-3(1)

Challenges in the Therapy of Secondary Hyperparathyroidism
pp. 4-8(5)
Authors: Wood, Carla; González, Esther A; Martin, Kevin J

Problems in Adapting the K/DOQI Guidelines for Japanese Patients with End Stage Renal Failure
pp. 9-10(2)
Author: Yokoyama, Keitaro

Combination Therapy with Sevelamer Hydrochloride and Calcium Carbonate in Japanese Patients with Long-Term Hemodialysis: Alternative Approach for Optimal Mineral Management
pp. 11-15(5)
Authors: Ogata, Hiroaki; Koiwa, Fumihiko; Shishido, Kanji; Kinugasa, Eriko

The Influence of Dialysate Calcium on the Therapeutic Effects of Sevelamer Hydrochloride in Hemodialysis Patients with Secondary Hyperparathyroidism Under Treatment of Intravenous Vitamin D Metabolites
pp. 16-23(8)
Authors: Ando, Ryoichi; Naito, Shotaro; Inagaki, Yuichro; Hata, Toshihiko; Ishida, Yuji; Chida, Yoshiko; Takayama, Masayuki; Tachibana, Ken; Ohtsuka, Masakazu; Inoue, Atsushi

Is 2.5 mEq/L the Optimal Calcium Concentration of Dialysate in the Use of Sevelamer Hydrochloride? A Study of the Dialysate Calcium Concentration Recommended by K/DOQI Guidelines
pp. 24-31(8)
Authors: Izumi, Masaaki; Shirai, Kenichi; Ito, Katsukiyo; Miyamoto, Takashi; Matsumoto, Akihide; Takenaka, Yoshiaki; Nakagawa, Kiyohiko; Yamanashi, Toshiaki; Takamitsu, Yoshihiro; Nakanish, Takeshi

Different Routes Bridging Calcium in Japanese Hemodialysis Patients
pp. 32-38(7)
Authors: Hamano, Takayuki; Fujii, Naohiko; Ito, Takahito; Imai, Enyu

Control of Parathyroid Function in Patients with a Short History of Hemodialysis
pp. 39-43(5)
Authors: Nishi, Hiroshi; Sato, Takashi; Kurihara, Toru; Kurosawa, Takeshi; Fukagawa, Masafumi

Surgical Indications and Procedures of Parathyroidectomy in Patients with Chronic Kidney Disease
pp. 44-47(4)
Authors: Tominaga, Yoshihiro; Matsuoka, Susumu; Sato, Tetsuhiko

Efficacy of Percutaneous Ethanol Injection Therapy for Secondary Hyperparathyroidism in Patients on Hemodialysis as Evaluated by Parathyroid Hormone Levels According to K/DOQI Guidelines
pp. 48-52(5)
Authors: Tanaka, Motoko; Itoh, Kazuko; Matsushita, Kazunori; Matsushita, Kazutaka; Fukagawa, Masafumi

LDL-Apheresis Accelerates the Recovery of Nonarteritic Acute Anterior Ischemic Optic Neuropathy
pp. 53-58(6)
Authors: Ramunni, Alfonso; Giancipoli, Giovanni; Guerriero, Silvana; Lapenna, Lucia; Saracino, Angelo; Saliani, Maria Teresa; Capurso, Antonio; Sborgia, Carlo; Coratelli, Pasquale

Prevention of Limb Amputation in Patients with Limbs Ulcers by Autologous Peripheral Blood Mononuclear Cell Implantation
pp. 59-63(5)
Authors: Kawamura, Akio; Horie, Takashi; Tsuda, Ichirou; Ikeda, Atushi; Egawa, Hirotoshi; Imamura, Emi; Iida, Jun-ichi; Sakata, Hiromi; Tamaki, Tohru; Kukita, Kazutaka; Meguro, Jun-ichi; Yonekawa, Motoki; Kasai, Masaharu

Study of Plasma Levels of Soluble CD40 Ligand in Systemic Lupus Erythematosus Patients Who Have Undergone Plasmapheresis
pp. 64-68(5)
Authors: Kimura, Kei; Tsuda, Hiroshi; Kwangseok, Yang; Tamura, Naoto; Kanai, Yoshinori; Kobayashi, Shigeto

Reversible Leukoencephalopathy Syndrome Associated to Leukopenia in a Chronic Hemodialysis Patient
pp. 69-73(5)
Authors: Salgado, Octavio J; Rosales, Beatriz C; García, Rafael

Symptomatic Bradycardia Probably Due to Tizanidine Hydrochloride in a Chronic Hemodialysis Patient
pp. 74-77(4)
Authors: Kitabata, Yukiko; Orita, Hikari; Kamimura, Motohiro; Shiizaki, Kazuhiro; Narukawa, Nobuhiko; Abe, Takaya; Kobata, Hirotsugu; Akizawa, Tadao

Low Volume Exchange Protocol for Peritoneal Dialysis After Abdominal Surgery
pp. 78-78(1)
Authors: Plevšičnik, Z; Lavre, J; Vujkovac, B; Pečolar, S

Renal Anemia Treatment In Peritoneal Dialysis Patients: A Multicenter Slovenian Study
pp. 78-78(1)
Authors: Pajek, J; Grego, K; Guček, A; Bevc, S; Ekart, R; Vujkovac, B; Golob Kosmina, P; Kandus, A; Bren, A F

Is Metabolism of Divalent Ions in Our Peritoneal Dialysis Population Optimal?
pp. 78-79(2)
Authors: Benedik, M; Guček, A

Endemic Nephropathy in Croatian Registry for Renal Replacement Therapy
pp. 79-79(1)
Authors: Čala, S

Ocular Changes in Hemodialysis Patients
pp. 79-79(1)
Authors: Pavlović, D; Vatavuk, Z; Vrabec, R; Čala, S; Sesar, A; Ratković-Gusić, I; Mandić, Z

The Most Important Factor for Cardiovascular Morbidity in Hemodialysis Patients is Microinflammation
pp. 79-80(2)
Authors: Lavre, J; Vujkovac, B; Šabović, M

Menstrual Dysfunction in Female Dialysis Patients
pp. 80-80(1)
Authors: Resić, H; Alajbegović, A; Sahović, V; Mesić, E; Suljić, E

Mixed Uremic Osteodystrophy – a Predominant Form of Renal Bone Disease in Slovenia
pp. 80-80(1)
Authors: Legan, M; Benedik, M; Kovač, D; Cör, A

The Effect of Handgrip Training and Intermittent Compression of Upper Arm Veins on Forearm Vessels in Patients With End-Stage Renal Failure
pp. 80-81(2)
Authors: Rus, R; Ponikvar, R; Kenda, R B; Buturović-Ponikvar, J

Comparison of Four Prognostic Indexes in Severe Acute Renal Failure
pp. 81-81(1)
Authors: Gubenšek, J; Ponikvar, R; Buturović-Ponikvar, J

Thrombolysis of Permanent Hemodialysis Catheters
pp. 81-81(1)
Author: Premru, V

Genotype and Transmission of Hepatitis C Virus in Hemodialysis Units
pp. 81-82(2)
Authors: Meši´, E; Tihić, N; Resić, H

Survival of Hemodialysis Patients Older Than 65 years: Influence of Albumin, Hemoglobin, and Cholesterol Concentration
pp. 82-82(1)
Authors: Orlić, L; Glažar, Ð Matić; Martinović, B Sladoje

Tuberculosis Skin Test in Chronic Hemodialysis Patients
pp. 82-82(1)
Authors: Urbančič, A; Premru, V; Knap, B; Benedik, M; Ponikvar-Buturović, J; Ponikvar, R; Bren, A F

Circulating Levels of Interleukin-6 in Hemodialysis Patients
pp. 82-82(1)
Authors: Rus, I; Avberšek-Lužnik, I

Treating of Nasal Carriers with Mupirocin and Prevention of Staphylococcus aureus Peritonitis and Esi/Ti in Peritoneal Dialysis Patients
pp. 83-83(1)
Authors: Guček, A; Karas, B; Pajek, J; Benedik, M

Osteoprotegerin and Bone Turnover Markers in Serum of Dialysis Patients
pp. 83-83(1)
Authors: Rus, I; Avberšek-Lužnik, I; Marc, J

Erythropoietin Requirements in Chronic Hemodialysis Patients After Failure of Kidney Transplant
pp. 83-84(2)
Authors: Škofic, N; Ponikvar, R; Bren, A F; Kandus, A; Varl, J; Malovrh, M; Buturović-Ponikvar, J

Effect of Intermittent Compression of Upper Arm Veins on Forearm Vessels in Patients with End-Stage Renal Disease
pp. 83-85(3)
Authors: Rus, R R; Ponikvar, R; Kenda, R B; Urbanˇiˇ, A; Buturović-Ponikvar, J

Early Arteriovenous Fistula Construction–Late Beginning of Hemodialysis Treatment?
pp. 85-85(1)
Author: Malovrh, M

Review of Treatment with Vitamin D: Ten Month Observation
pp. 85-85(1)
Authors: Malovrh, M; Premru, V

Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis: One Center Study
pp. 86-86(1)
Authors: Malovrh, M; Premru, V

Review of Treatment with Epoetin: 10 Months Observation
pp. 86-86(1)
Authors: Malovrh, M; Premru, V

Response on Epoetin Treatment is Poor in Hemodialysed Patients with Low Creatinine and Albumin Values
pp. 86-87(2)
Authors: Knap, B; Lainščak, M; Varl, J; Bren, AF

Frequent Low-Dose Iron Supplementation To Hemodialysis Patients
pp. 87-87(1)
Authors: Premru, V; Malovrh, M

Regional Citrate Anticoagulation During Hemodialysis: Our Experiences
pp. 87-88(2)
Authors: Buturović-Ponikvar, J; Čatak, S; Benedik, M; Varl, J; Knap, B; Pernat, A Marn; Kandus, A; Guček, A; Premru, V; Malovrh, M; Gubenšek, J; Škofic, N; Gaber, L; Bren, A F; Ponikvar, R

Citrate Anticoagulation for Single-Needle Hemodialysis: Safety and Efficacy
pp. 88-88(1)
Authors: Buturović-Ponikvar, J; Gubenšek, J; Ponikvar, R

The Influence of Aerobic Training During Hemodialysis Procedure on Blood Pressure, Heart Rate and Aerobic Capacity of Chronic Hemodialysis Patients
pp. 88-88(1)
Authors: Fazlić, S; Ponikvar, R; Buturović-Ponikvar, J

Temporary Hemodialysis Catheters as a Long Term Vascular Access in Chronic Hemodialysis Patients
pp. 88-89(2)
Authors: Ponikvar, R; Likar, C; Premru, V; Benedik, M; Varl, J; Knap, B; Urbančič, A; Marn-Pernat, A; Buturović-Ponikvar, J

Increased Mercury Load in Protein A Immunoadsorption
pp. 89-89(1)
Authors: Pernat, A Marn; Horvat, M; Logar, M; Ponikvar, R

Plasma Exchange Therapy for Severe Hypertriglyceridemia with Acute Pancreatitis
pp. 89-90(2)
Authors: Ponikvar, R; Marn-Pernat, A.; Žugić, R.; Varl, J; Benedik, M; Buturović-Ponikvar, J

Chronic LDL Apheresis in Children and Young Adults
pp. 90-90(1)
Authors: Ponikvar, R; Žugić, R; Fejzuli, Č; Dedič, H; Gaber, L; Buturović-Ponikvar, J

Citrate Anticoagulation during Plasma Exchange in Patients with Thrombotic Thrombocytopenic Purpura – Short Heparin-Free Hemodialysis Helps to Remove Citrate Load
pp. 90-91(2)
Authors: Buturović-Ponikvar, J; Fejzuli, Č; Ponikvar, R

Chronic Immunoadsorption/Plasma Exchange in Patients With Recurrence of Focal Segmental Glomerular Sclerosis After Kidney Transplantation
pp. 91-91(1)
Authors: Ponikvar, R; Kandus, A; Bren, A; Buturović-Ponikvar, J

The Survey of Kidney Transplantation in Slovenia: The First Four Years Since Joining The Eurotransplant
pp. 91-91(1)
Authors: Arnol, M; Kovaš, D; Bren, A F; Kandus, A

Prevention of Early Acute Rejection with Basiliximab and Triple Immunosuppression in Cadaveric Renal Allograft Recipients
pp. 91-92(2)
Authors: Kandus, A; Grego, K; Arnol, M; Kovač, D; Kovač, J; Lindič, J; Buturović-Ponikvar, J; Ponikvar, R; Bren, A F

Prevention of Early Acute Rejection with Daclizumab and Triple Immunosuppression in Cadaveric Renal Allograft Recipients
pp. 92-92(1)
Authors: Kandus, A; Grego, K; Arnol, M; Kovač, D; Kovač, J; Lindič, J; Bren, A F

Long-term Follow-up of Renal Transplant Artery Stenosis: Case Controlled Study
pp. 92-92(1)
Authors: Župunski, A; Kandus, A; Buturović-Ponikvar, J

De Novo Malignancies After Renal Transplantation – A Single Center Experience
pp. 92-93(2)
Authors: Ivanovski, N; Popov, Z; Kolevski, P; Čakalaroski, K; Masin, J; Zafirovska, K

Does Mycophenolate Mofetil Increase the Incidence of Cytomegalovirus Disease Compared To Azathioprine After Cadaveric Kidney Transplantation?
pp. 93-93(1)
Authors: Bubić-Filipi, L; Bašić-Jukić, N; Puretić, Z; Barišić, I; Šmalcelj, R; Pasini, J; Kes, P

Serum C-Reactive Protein in Kidney Transplant Patients – A Useful Marker of Immune Activation
pp. 93-93(1)
Authors: Bubić-Filipi, L; Barišić, I; Hršak Puljić, I; Bašić-Jukić, N; Puretić, Z; Kes, P

Follow-up of Kidney Graft Recipients with Cyclosporine Associated Hemolytic Uremic Syndrome and Thrombotic Microangiopathy
pp. 93-94(2)
Authors: Bren, A; Kandus, A; Buturović-Ponikvar, J; Lindič, J; Knap, B; Pajek, J; Grego, K; Vizjak, A; Ferluga, D

Conversion To Tacrolimus Due To Cyclosporine-Related Toxicity in Kidney Graft Recipients – Single Center Study
pp. 94-94(1)
Authors: Bren, A F; Pajek, J; Grego, K; Kandus, A

Infection with Hepatitis B or Hepatitis C Viruses in Patients with Renal Transplants in Slovenia
pp. 94-94(1)
Authors: Kovač, J; Kandus, A; Bren, A F; Levičnik, S

Renal Transplant Artery Stenosis: The Possible Association With Acute Rejection Episodes and Immunosuppressive Treatment
pp. 94-95(2)
Authors: Župunski, A; Kandus, A; Bren, AF; Buturović-Ponikvar, J

Hypercalcemic Nephropathy and TNFα in Patients with Bronchial Carcinoma
pp. 95-95(1)
Authors: Čakalaroski, K; Crvenkova, S; Ivanovski, N; Jovanovski, D

Glomerular Filtration Rate in Convalescents with Hemorrhagic Fever with Renal Syndrome
pp. 95-96(2)
Authors: Tulumović, D; Mešić, E; Hukić, M; Živković, N

Polymorphisms In α-Adducin (G460w) and G-Protein β-3 Subunit (C825t) Genes In Essential Hypertension
pp. 96-96(1)
Authors: Marčun Varda, N; Zagradišnik, B; Vokač, N Kokalj; Gregorič, A

Mutation Screening in Patients with Vesico-Ureteric Reflux
pp. 96-96(1)
Authors: Zagradišnik, B; Bračič, K; Varda, N Marčun; Vokač, N Kokalj; Gregorič, A

Twenty-four-hour Ambulatory Blood Pressure Monitoring in Healthy Infants
pp. 96-97(2)
Authors: Varda, N Marčun; Gregorič, A

Abstracts Index
pp. 98-98(1)

Upcoming Meetings
pp. 99-101(3)

Letter to the Editor
pp. 102-102(1)